Today: 11 June 2026
Westpac share price slips after ASX rout — what to watch before WBC’s Feb. 13 update
8 February 2026
1 min read

Westpac share price slips after ASX rout — what to watch before WBC’s Feb. 13 update

Sydney, Feb 8, 2026, 17:17 AEDT — Market closed.

  • Westpac ended Friday at A$39.43, slipping 1.2%.
  • Financials sank as the broader ASX slipped, pulling the mood lower heading into Monday’s session.
  • Westpac’s first-quarter update drops Feb. 13, and investors are watching closely for signals on margins and credit quality.

Westpac Banking Corp (WBC.AX) slipped 1.2% on Friday, wrapping up the session at A$39.43. Shares moved within a band from A$39.15 up to A$39.995, compared to Thursday’s close of A$39.91.

Australian stocks had a rough run, notching their sharpest one-day fall in nearly a year. The S&P/ASX 200 ended down 2%, erasing roughly A$70 billion in value, ABC reported. “Panic is spreading,” said Michael McCarthy, an analyst at MooMoo Australia. Financials took a 1.5% hit. ABC News

Here’s what’s in play now: banks are working to squeeze more profit from rising rates, while keeping a close eye on what they’re paying for funding and the risk of sour loans. The Reserve Bank of Australia just lifted its cash rate to 3.85% on Tuesday—marking the first increase in two years. Westpac responded, announcing it will bump up its variable home loan rate by 25 basis points, or a quarter point, effective Feb. 17.

This tees up the next debate around Westpac: does charging more actually boost net interest margin—the gap between loan earnings and funding costs—or does pressure from rivals in deposits and mortgages just squeeze any upside?

Plenty of the discussion spills into the bank’s first-quarter update. Traders are zeroing in on shifts in mortgage volumes, tweaking of deposit pricing, and whether there’s any whiff of borrower stress appearing early.

The rate change isn’t isolated. Should volatility ripple through bank funding markets, wholesale funding costs might jump—chipping away at whatever boost banks might get from higher loan rates.

Westpac faces the challenge of holding onto its share in a packed home-loan market. If it tries to win over customers with aggressive pricing, the impact on margins rarely stays hidden for long—those details turn up fast in earnings calls. Commonwealth Bank, NAB and ANZ remain the obvious benchmarks here.

The risk cuts both ways. Should elevated rates hit households more sharply, arrears might climb, dragging credit costs up—even ahead of any slowdown showing up in the economic data.

Westpac heads into Monday with sentiment shaky across the board, investors picking apart whether Friday’s risk-off slide was a blip or something more entrenched.

Westpac drops its first-quarter update on Friday, with an investor call kicking off at 8 a.m. Sydney time. Investors will be hunting for any change in management’s stance on margins, costs, or credit quality, as fresh rate adjustments are set to filter through later this month.

Stock Market Today

  • What is an IPO as SpaceX Prepares for U.S. Stock Market Debut
    June 10, 2026, 6:01 PM EDT. An IPO, or Initial Public Offering, is when a private company sells shares to the public for the first time, becoming publicly traded. SpaceX, the aerospace manufacturer, is expected to make its debut on the U.S. stock market, marking one of the most anticipated IPOs in recent years. This move allows retail and institutional investors to buy equity in SpaceX, potentially impacting the space industry and tech sectors. The IPO process involves regulatory filings, pricing, and public trading, providing companies with capital for expansion. SpaceX's offering could reshape market dynamics, drawing significant investor interest given its innovations and growth trajectory.

Latest articles

Parabilis Medicines (PBLS) soars 58% after $670 million IPO beats range

Parabilis Medicines (PBLS) soars 58% after $670 million IPO beats range

10 June 2026
Parabilis Medicines soared 58% above its $20 IPO price to close at $31.60 in its Nasdaq debut after raising a record $670 million, reflecting strong investor demand for its Helicon drug platform ahead of a pivotal Phase 3 desmoid tumor trial planned for 2027; Regeneron’s $75 million private placement added credibility.
Joby Aviation Shares Slip After CFO Files to Sell Stock

Joby Aviation Shares Slip After CFO Files to Sell Stock

10 June 2026
Joby Aviation fell 4.47% to $8.86 after CFO Rodrigo Brumana disclosed selling 78,489 shares under a prearranged 10b5-1 plan, with no new certification or commercial-launch updates, leaving investors focused on regulatory progress and cash burn as the key catalysts for the stock.
YY Group Shares Spike as Humanoid Robot Plans Unveiled

YY Group Shares Spike as Humanoid Robot Plans Unveiled

10 June 2026
YY Group Holding shares surged to $0.165 on heavy volume after announcing a commercial humanoid-robotics initiative using Unitree G1 robots and facility-management data, reframing the company as a robotics-and-AI data play; the rally comes despite 2025 net loss, dilution risk from a relaunched at-the-market share-sale program, and no disclosed robot-related revenue or contracts.
Fortescue share price set for Monday test as Cyclone Mitchell shuts Port Hedland
Previous Story

Fortescue share price set for Monday test as Cyclone Mitchell shuts Port Hedland

Windows 11 printer alert: Microsoft tightens the screws on legacy V3/V4 drivers in 2026
Next Story

Windows 11 printer alert: Microsoft tightens the screws on legacy V3/V4 drivers in 2026

Go toTop